Lenalidomide Impurity 37 CAS 1198299-72-7

Purity >95%In StockPharmacopoeial Impurity Standards
CAS No.1198299-72-7
Molecular FormulaC13H13N3O6
Molecular Weight307.26 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Lenalidomide Impurity 37 CAS 1198299-72-7 chemical structure

Description

CATO supplies Lenalidomide Impurity 37 (CAS 1198299-72-7), a pharmacopoeial impurity reference standard (molecular formula C13H13N3O6, MW 307.26 g/mol) used for the identification and quantification of trace impurities in APIs.

Based on its molecular formula C13H13N3O6, Lenalidomide Impurity 37 contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 307.26 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

CATO manufactures Lenalidomide Impurity 37 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC13H13N3O6
Molecular Weight307.26 g/mol
AppearancePale yellow to yellow crystalline powder
Purity>95%
StorageStore at 2-8°C, protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)9.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1989
Nitrogen Atoms3

Related Lenalidomide Standards

Recommended Standards

Why CATO?